Studies Report Rapid Loss of COVID-19 Antibodies
Studies Report Rapid Loss of COVID-19 Antibodies
The results, while preliminary, suggest that survivors of SARS-CoV-2 infection may be susceptible to reinfection within weeks or months.
Studies Report Rapid Loss of COVID-19 Antibodies
Studies Report Rapid Loss of COVID-19 Antibodies

The results, while preliminary, suggest that survivors of SARS-CoV-2 infection may be susceptible to reinfection within weeks or months.

The results, while preliminary, suggest that survivors of SARS-CoV-2 infection may be susceptible to reinfection within weeks or months.

immunology
The Scientist Speaks Podcast – Episode 6
The Scientist Speaks Podcast – Episode 6
The Scientist Creative Services Team | Jun 30, 2020
A Game of Cancer and Evolution
Could Statins Reduce the Severity of COVID-19?
Could Statins Reduce the Severity of COVID-19?
Ashley Yeager | Jun 12, 2020
The cholesterol-lowering drugs quell inflammation and reverse endothelial tissue damage, hints that they might curb the body’s excessive immune response to SARS-CoV-2 infection.
Improving COVID-19 Treatment & Vaccine Development by Modulating the Immune Response: Applying Single-Cell Proteomics 
Improving COVID-19 Treatment & Vaccine Development by Modulating the Immune Response: Applying Single-Cell Proteomics 
The Scientist Creative Services Team | Jun 10, 2020
James R. Heath, PhD, President of the Institute for Systems Biology will discuss key single-cell learnings and applications from the large Seattle-based academic pharmaceutical consortium committed to defining molecular mechanisms of SARS-CoV-2 infection and identifying potential prognostic immune biomarkers. Stacey Willard, PhD, from IsoPlexis will discuss how functional phenotyping individual immune cells using IsoPlexis technology edges researchers closer to predicting the risk for severe disease. 
First Antibody Trial Launched in COVID-19 Patients
First Antibody Trial Launched in COVID-19 Patients
Katarina Zimmer | Jun 2, 2020
In record time, scientists have gone from harvesting antibodies against SARS-CoV-2 from survivors of coronavirus infections to testing the antibodies’ safety as a drug in humans.
The Father of Autoimmunity: A Profile of Noel Rose
The Father of Autoimmunity: A Profile of Noel Rose
Diana Kwon | Jun 1, 2020
By revealing that animals could develop immune responses against their own tissues, the physician-scientist established an entirely new field of science.
Host Cells Release Exosomes to Sop Up Bacterial Toxins
Host Cells Release Exosomes to Sop Up Bacterial Toxins
Rachael Moeller Gorman | Jun 1, 2020
During bacterial infection, autophagy proteins appear to regulate the release of cell-saving exosomes, which bear the brunt of toxin damage.
Infographic: How Cells Use Decoys to Defend Against Pathogens
Infographic: How Cells Use Decoys to Defend Against Pathogens
Rachael Moeller Gorman | Jun 1, 2020
Specialized exosomes sop up bacterial toxins, a study finds.
Neutrophil Extracellular Traps May Augur Severe COVID-19
Neutrophil Extracellular Traps May Augur Severe COVID-19
Alakananda Dasgupta | May 28, 2020
These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.
COVID-19 Vaccine Researchers Mindful of Immune Enhancement
COVID-19 Vaccine Researchers Mindful of Immune Enhancement
Katarina Zimmer | May 26, 2020
There is no evidence that any of the coronavirus vaccines in development worsen a coronavirus infection rather than confer immunity to it, but the phenomenon is something scientists are closely monitoring.